Susan Piascik Christoff

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.

Cooley is advising Veritone, an artificial intelligence company, on its acquisition of Broadbean for $52 million.

Cooley advised UiPath, the world’s leading robotics process automation software company, on its $1.5 billion initial public offering of 27,474,393 shares of Class A common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Partners Nicole Brookshire, Eric Jensen and Matthew Dubofsky led the Cooley team advising UiPath.

Cooley advised Sazerac, an operator of a distilling company, on its agreement to acquire 19 alcoholic beverage brands from Diageo for $550 million. Partner Ben Beerle led the team.

Cooley is advising alcoholic beverages company Sazerac on its acquisition of the Southern Comfort and Tuaca brands from Brown-Forman for $543.5 million.

The sale is expected to close by March. Sazerac is one of New Orleans' oldest family owned, privately held companies.